Pathogenesis of pneumococcal infection

Journal of Medical Microbiology

Volumn 49, Issue 12, 2000, Pages 1057-1067

  Gillespie, S H ^a   Balakrishnan, I ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; LUNG; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PRIORITY JOURNAL; STREPTOCOCCUS INFECTION;

EID: 0033667764     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-49-12-1057     Document Type: Article

References (100)

1. Studies on gonococcus infection XIII. Occurrence of color/opacity colonial variants in clinical cultures
2. Relationship between colony morphology and the life cycle of Haemophilus influenzae: The contribution of lipopolysaccharide phase variation to pathogenesis
3. Pneumococcus variants. I. Intermediate forms and the influence of environment in their production during in vitro S to R and R to S transitions
4. Phase variation in pneumococcal opacity: Relationship between colonial morphology and nasopharyngeal colonization
5. Relationship between colonial morphology and adherence of Streptococcus pneumoniae
6. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor
7. The genetic basis of colony opacity in Streptococcus pneumoniae: Evidence for the effect of box elements on the frequency of phenotypic variation
8. Relationship between phase variation in colony morphology, interstrain variation in cell wall physiology and nasopharyngeal colonization by Streptococcus pneumoniae
9. Association of intrastrain phase variation in quantity of capsular polysaccharide and teichoic acid with the virulence of Streptococcus pneumoniae
10. Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae
11. Identification of an active disaccharide unit of a glycoconjugate receptor of pneumococci attaching to human pharyngeal epithelial cells
12. A sandwich adhesion on Streptococcus pneumoniae attaching to human oropharyngeal epithelial cells in vitro
13. Differing roles for platelet-activating factor during inflammation of the lung and the subarachnoid space. The special case of Streptococcus pneumoniae
14. The cell wall mediates pneumococcal attachment to and cytopathology in human endothelial cells
15. Molecular and cellular biology of pneumococcal infection
16. Nucleotide sequence analysis of a type 1 fimbrial gene of Streptococcus sanguis FW213
17. Nucleotide sequence of a gene coding for a saliva-binding protein (SsaB) from Streptococcus sanguis 12 and possible role of the protein in coaggregation with actinomyces
18. Penicillin tolerance genes of Streptococcus pneumoniae: The ABC-type manganese permease complex Psa
19. Sequence heterogeneity of PsaA, a 37-kilodalton putative adhesin essential for virulence of Streptococcus pneumoniae
20. PspA and PspC: Their potential for use as pneumococcal vaccines
21. Versatility of choline-binding domain
22. Pneumococcal trafficking across the blood brain barrier. Molecular analysis of a novel bidirectional pathway
23. The molecular basis of pneumococcal infection. A hypothesis
24. Early predictors of mortality in pneumococcal bacteraemia
25. A multilocus sequence typing scheme for Streptococcus pneumoniae: Identification of clones associated with serious invasive disease
26. A study of pathogenic factors of Streptococcus pneumoniae strains causing meningitis
27. The role of hyaluronidase in the occurrence of a generalized pneumococcal infection
28. Effect of lacto-N-neotetraose, asialoganglioside-GM1 and neuraminidase on adherence of otitis media-associated serotypes of Streptococcus pneumoniae to chinchilla tracheal epithelium
29. Cloning and characterization of nanB, a second Streptococcus pneumoniae neuraminidase gene, and purification of the NanB enzyme from recombinant Escherichia coli
30. Neuraminidase activity in bacterial meningitis
31. PspA, a surface protein of Streptococcus pneumoniae, is capable of eliciting protection against pneumococci of more than one capsular type
32. Monoclonal antibodies against protease-sensitive pneumococcal antigens can protect mice from fatal infection with Streptococcus pneumoniae
33. Structural properties and evolutionary relationships of PspA, a surface protein of Streptococcus pneumoniae, as revealed by sequence analysis
34. Protection of mice against fatal pneumococcal challenge by immunization with pneumococcal surface adhesin A (PsaA)
35. Truncated forms of PspA that are secreted from Streptococcus pneumoniae and their use in functional studies and cloning of the pspA gene
36. Identification of pneumococcal surface protein A as a lactoferrin-binding protein of Streptococcus pneumoniae
37. Effect of immunization with pneumolysin on survival time of mice challenged with Streptococcus pneumoniae
38. Reduced virulence of a defined pneumolysin-negative mutant of Streptococcus pneumoniae
39. Membrane damage by poreforming bacterial cytolysins
40. Pneumolysin stimulates production of tumor necrosis factor alpha and interleukin-1 beta by human mononuclear phagocytes
41. Molecular studies of pneumolysin as an aid to vaccine design
42. Pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae, does not require a thiol group for in vitro activity
43. A role in cell-binding for the C-terminus of pneumolysin, the thiolactivated toxin of Streptococcus pneumoniae
44. The family of the antigenically-related cholesterol-binding ('sulphydryl activated') cytolytic toxins
45. Characterization of the solution properties and conformation of pneumolysin, the membrane-damaging toxin of Streptococcus pneumoniae
46. Modeling the bacterial protein toxin, pneumolysin, in its monomeric and oligomeric form
47. Subunit organisation and symmetry of poreforming, oligomeric pneumolysin
48. The molecular mechanism of pneumolysin, a virulence factor from Streptococcus pneumoniae
49. Interaction of pneumolysin-sufficient and -deficient isogenic variants of Streptococcus pneumoniae with human respiratory mucosa
50. Inhibition of human polymorphonuclear leukocyte respiratory burst, bactericidal activity and migration by pneumolysin
51. Complement and the host's defence against the pneumococcus
52. Role of pneumolysin's complement-activating activity during pneumococcal bacteraemia in cirrhotic rats
53. Pneumolysin activates phospholipase A in pulmonary artery endothelial cells
54. Activation of human complement by the pneumococcal toxin pneumolysin
55. Pneumolysin, a protein toxin of Streptococcus pneumoniae, induces nitric oxide production from macrophages
56. Mechanism of phenotypic tolerance of nongrowing pneumococci to beta-lactam antibiotics
57. Structural organization of the major autolysin from Streptococcus pneumoniae
58. Protein-bound choline is released from the pneumococcal autolytic enzyme during adsorption of the enzyme to cell wall particles
59. Structural characterization of the unligated choline-bound forms of the major pneumococcal autolysin LytA amidase
60. Structural studies of the lysozome coded by the pneumococcal phage Cp-1. Conformation changes induced by choline
61. Allelic variation in Streptococcus pneumoniae autolysin (N-acetyl muramoyl-L-alanine amidase)
62. The autolysin-encoding gene lytA of Streptococcus pneumoniae displays restricted allelic variation despite localized recombination events with genes of pneumococcal bacteriophage encoding cell wall lytic enzymes
63. Contribution of autolysin to virulence of Streptococcus pneumoniae
64. The induction of meningeal inflammation by components of the pneumococcal cell wall
65. The nature of cell wall-derived inflammatory components of pneumococci
66. Induction of pulmonary inflammation by components of the pneumococcal cell surface
67. Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall
68. Activation of the alternative complement pathway by pneumococcal lipoteichoic acid
69. Roles of autolysin and pneumolysin in middle ear inflammation caused by a type 3 Streptococcus pneumoniae strain in the chinchilla otitis media model
70. Pharmacodynamics of antibiotics in the therapy of meningitis: Infection model observations
71. Antigenemia in fulminant pneumococcemia
72. Detection of C-polysaccharide in serum of patients with Streptococcus pneumoniae bacteraemia
73. Protection of mice from infection with Streptococcus pneumoniae by antiphosphocholine antibody
74. Human C-reactive protein is protective against fatal Streptococcus pneumoniae infection in mice
75. Monoclonal idiotype vaccine against Streptococcus pneumoniae infection
76. Phase variation in colony opacity by Streptococcus pneumoniae
77. Mechanisms of host defense against infection with Streptococcus pneumoniae
78. Role of complement in C-reactive-protein-mediated protection of mice from Streptococcus pneumoniae
79. Cytokine kinetics and other host factors in response to pneumococcal pulmonary infection in mice
80. Coexistence of CD14-dependent and independent pathways for stimulation of human monocytes by Gram-positive bacteria
81. Production of interleukin-1 but not tumor necrosis factor by human monocytes stimulated with pneumococcal cell surface components
82. Role of tumor necrosis factor alpha in pathogenesis of pneumococcal pneumonia in mice
83. Interleukin-10 impairs host defense in murine pneumococcal pneumonia
84. Intefieukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia
85. The influence of fever on the development of experimental Streptococcus pneumoniae meningitis
86. The relative role of bacterial cell wall and capsule in the induction of inflammation in pneumococcal meningitis
87. Serotype-related differences in inflammatory response to Streptococcus pneumoniae in experimental meningitis
88. Differences of pathophysiology in experimental meningitis caused by three strains of Streptococcus pneumoniae
89. Induction of meningeal inflammation by diverse bacterial cell walls
90. Morphologic alterations of the blood-brain barrier with experimental meningitis in the rat. Temporal sequences and role of encapsulation
91. Complement (C5)-derived chemotactic activity accounts for accumulation of polymorphonuclear leukocytes in cerebrospinal fluid of rabbits with pneumococcal meningitis
92. Pathophysiology of pneumococcal meningitis
93. Pneumococcal meningitis: Current pathophysiologic concepts
94. Experimental pneumococcal meningitis: Role of leukocytes in pathogenesis
95. Measurement of the third component of complement in cerebrospinal fluid by modified electroimmunodiffusion
96. Cerebrospinal-fluid immunoglobulins in meningitis
97. Effect of hydration status on cerebral blood flow and cerebrospinal fluid lactic acidosis in rabbits with experimental meningitis
98. Cerebrospinal fluid outflow resistance in rabbits with experimental meningitis. Alterations with penicillin and methylprednisolone
99. Brain edema, intracranial pressure and cerebral blood flow in bacterial meningitis
100. Near-infrared spectroscopy in experimental pneumococcal meningitis in the rabbit: Cerebral hemodynamics and metabolism